GlassScriptPhysician profile
Brian H Lewis
NPI 1588748339
$1,978.63
in general payments reported to CMS, 2019-2025
33 companies · $267 in 2025
The $267 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $171 · 2020: $138 · 2021: $209 · 2022: $408 · 2023: $431 · 2024: $354 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,052.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,052.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $335.09 | 2019-2025 | Breztri, Farxiga, Airsupra |
| Novo Nordisk INC | $189.17 | 2019-2024 | |
| Abbvie INC. | $180.27 | 2022-2025 | |
| Astellas Pharma US INC | $177.01 | 2019-2024 | Veozah |
| Novartis Pharmaceuticals Corporation | $145.38 | 2019-2024 | |
| Glaxosmithkline, LLC. | $133.72 | 2020-2025 | Trelegy Ellipta |
| Pfizer INC. | $102.39 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $86.03 | 2023-2025 | |
| Abbott Laboratories | $73.28 | 2022-2023 | Freestyle Libre 3 |
| Nestle Healthcare Nutrition INC. | $70.69 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $35.34 | 2019 | |
| Amgen INC. | $34.92 | 2022-2025 | Otezla, Repatha |
| Avanir Pharmaceuticals, INC. | $33.95 | 2022 | |
| Scilex Pharmaceuticals INC. | $29.94 | 2024 | |
| Boston Scientific Corporation | $24.80 | 2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $24.49 | 2023 | Darzalex |
| Otsuka America Pharmaceutical, INC. | $21.70 | 2023 | Rexulti |
| Amarin Pharma, INC. | $21.39 | 2020 | |
| Inspire Medical Systems, INC. | $20.97 | 2025 | Inspire |
| Takeda Pharmaceuticals U.S.A., INC. | $20.91 | 2023 | Trintellix |
| Idorsia Pharmaceuticals US INC | $20.55 | 2023 | Quviviq |
| Biohaven Pharmaceuticals, INC. | $19.51 | 2021 | |
| Ultragenyx Pharmaceutical INC. | $19.31 | 2024 | Crysvita |
| Teva Pharmaceuticals USA, INC. | $19.25 | 2024 | Austedo Xr |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $19.17 | 2024 | Caplyta |
| Medtronic, INC. | $19.12 | 2025 | Inceptiv |
| Array Biopharma INC | $17.59 | 2025 | Lorbrena, Braftovi, Mektovi |
| Exact Sciences Corporation | $16.31 | 2025 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $15.62 | 2025 | Zoryve |
| Biohaven Pharmaceutical Holding Company LTD. | $14.47 | 2022 | |
| Horizon Therapeutics Plc | $12.53 | 2019 | |
| Corium, LLC | $12.13 | 2023 | Adlarity |
| Sunovion Pharmaceuticals INC. | $11.63 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.